Details of the Drug

General Information of Drug (ID: DMQW612)

Drug Name
Ad5f35-LMPd1-2-transduced autologous dendritic cells
Synonyms
AddLMP1-I-LMP2; LMP1/LMP2 cytotoxic T-lymphocytes vaccine (nasopharyngeal cancer), Baylor College of Medicine; Ad5f35-LMPd1-2-transduced autologous dendritic cells (EBV-associated cancer); Ad5f35-LMPd1-2-transduced autologous dendritic cells (EBV-associated cancer),NCI
Indication
Disease Entry ICD 11 Status REF
Nasopharyngeal carcinoma 2B6B Investigative [1]
Drug Type
Vaccine
Cross-matching ID
TTD ID
D0Q8PF

Molecular Interaction Atlas of This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Epstein-Barr virus Latent membrane protein 1 (EBV LMP1) TT0BI4Q LMP1_EBVG Not Available [1]
Epstein-Barr virus Latent membrane protein 2 (EBV LMP2) TTBK351 LMP2_EBVB9 Not Available [1]
Molecular Interaction Atlas (MIA) Jump to Detail Molecular Interaction Atlas of This Drug

References

1 CA patent application no. 876139, Nanotherapeutics for drug targeting.